Use of a topical composition containing epidermal growth factor (EGF) for diabetic foot amputation prevention

Details for Australian Patent Application No. 2006331223 (hide)

International Classifications

Event Publications

21 August 2008 PCT application entered the National Phase

PCT publication WO2007/073704 Priority application(s): WO2007/073704

11 September 2008 Corrigenda

PCT applications that have entered the National Phase - Name Index Under the name Centro de Ingenieria Genetica y Biotecnologia, Application No. 2006331223, under INID (54), correct the title to read Use of a topical composition containing epidermal growth factor (EGF) for diabetic foot amputation prevention.

22 December 2011 Application Accepted

Published as AU-B-2006331223

19 April 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.